Jim Lubinsky

Jim is a seven year myeloma patient who experienced a daratumumab trial in 2015 and autologous stem cell in 2017 and has personally consulted with five myeloma doctor specialists in his journey. Today he is MRD negative and off treatment.  Jim also has coached over 30 myeloma patients in their journeys. He is a strong believer in "Self Advocacy".